Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer
2011

NDRG2 Expression in Human Cancers, Especially Breast Cancer

Sample size: 154 publication Evidence: moderate

Author Information

Author(s): Lorentzen Anders, Lewinsky Rikke H, Bornholdt Jette, Vogel Lotte K, Mitchelmore Cathy

Primary Institution: Roskilde University

Hypothesis

The study aims to examine levels of NDRG2 mRNA in several human cancers, focusing on breast cancer.

Conclusion

NDRG2 mRNA levels are significantly reduced in thyroid and breast cancer compared to normal tissue.

Supporting Evidence

  • NDRG2 mRNA was reduced by at least 2-fold in almost a third of the tumor samples compared to normal tissue.
  • A significant reduction in NDRG2 mRNA was observed in breast cancer and thyroid cancer samples.
  • MYC mRNA levels were not significantly altered in breast cancer or thyroid gland cancer.

Takeaway

This study looked at a gene called NDRG2 in different cancers and found that it is lower in breast cancer, which might help us understand cancer better.

Methodology

The study used a Cancer Profiling Array and quantitative real-time RT-PCR to evaluate NDRG2 mRNA levels in paired normal and tumor samples.

Limitations

The sample sizes for some cancer types were small, which may limit the conclusions that can be drawn.

Participant Demographics

The study included samples from both male and female patients with various cancers, with mean ages ranging from 40.3 to 65.5 years.

Statistical Information

P-Value

0.004

Confidence Interval

95% CI not specified

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-11-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication